Introduction
Biofi lms are differentiated microorganism communities, formed by a single microbial agent or by a mixture of fungal and/or bacterial species, which adheres to a biotic or abiotic surface, and is diffi cult to remove [1 -3] . This structure contributes to the innate physical and chemical resistance of the microorganisms and is responsible for cooperative degradation of complex nutrients and community-based regulation of gene expression [4, 5] . Indeed, biofi lm formation plays an important role in resistance to antimicrobial agents, with sessile cells up to ∼ 2000 times more resistant than planktonic cells [3,6 -9] . In addition, biofi lm formation contributes to the chronic status of many diseases caused by microorganisms, resulting in recurring symptoms even after treatment [1, 10] . The capability to form biofi lms has been demonstrated in many yeast genera, such as Candida , Trichosporon , Cryptococcus , Blastoschizomy-e.g., Candida spp. [23] . Nonetheless, a potential relationship between antifungal resistance and biofi lm formation in M. pachydermatis cells has never been explored. Thus, the aim of this study was to evaluate the antifungal resistance of sessile (i.e., biofi lm) and planktonic M. pachydermatis cells to FLZ, KTZ, ITZ, miconazole (MICO), posaconazole (POS), terbinafi ne (TER) and voriconazole (VOR) antifungal drugs.
Material and methods

Malassezia isolates and identifi cation
Malassezia pachydermatis isolates were collected from 60 dogs, with or without skin lesions, and cultured using modifi ed Dixon agar [24] . Isolates were separated into two groups, i.e., Group A comprising 31 isolates collected from skin of healthy dog and Group B, consisting 29 isolates recovered from dogs presenting skin lesions. M. pachydermatis strains were identifi ed phenotypically (via macroscopic and microscopic morphology) and by their ability to grow on medium without lipid supplementation [25] . Isolates were maintained on modifi ed Dixon agar and deposited in the fungal collection of the Department of Veterinary Medicine (Unit of Mycology and Parasitology) at the University of Bari (Italy).
In vitro susceptibility testing of planktonic cells
The in vitro antifungal susceptibility of M. pachydermatis planktonic cells was determined using the Clinical and Laboratory Standards Institute (CLSI) broth microdilution method as previously described [26 -30] . Specifi cally, inoculum suspensions of M. pachydermatis strains were prepared from 7-day-old colonies grown on modifi ed Dixon agar at 32 ° C. Sabouraud Dextrose broth (Liofi lchem Diagnostici, Roseto degli Abruzzi, Italy) with 1% of Tween 80 (Sigma Co, Milano, Italy) was used as the growth medium in the susceptibility studies. The fi nal concentration of the inoculum suspensions was equivalent to 1 -5 ϫ 10 6 CFU/ml (optical density of 2.4 using a DEN-1 McFarland Densitometer (Biosan) [28] ).
The following antifungal drugs were supplied by the manufacturers as pure compounds: KTZ, MICO, ITZ and TER (Sigma-Aldrich, Milan, Italy), FLZ and VOR (Pfi zer Pharmaceuticals, Groton, CT, USA) and POS (ScheringPlough Corporation, Kenilworth, NJ, USA). The fi nal concentrations of each antifungal drug ranged from 0.008 -16 mg/l, with the exception of FLZ (0.03 -64 mg/l). After 48 h at 32 ° C, plates were read and the growth of each strain at various drug concentrations assessed [27 -30] . Drug-free medium was used as the positive control and each plate was run in duplicate. The minimum inhibitory concentration (MIC) was defi ned as the lowest concentration of the drug which produces a noticeable decrease in turbidity (i.e., 90% growth inhibition) compared to the positive control [28, 31] . The MIC results reported are the concentrations where growth of 50% of tested isolates was inhibited (MIC50). Quality control strains ( Candida parapsilosis ATCC 22019 and Candida krusei ATCC 6258; American Type Culture Collection, Manassas, VA, USA) were included to check the accuracy of the drug dilutions and reproducibility of the results [32] .
In vitro susceptibility testing of Malassezia pachydermatis sessile cells
In vitro susceptibility of M. pachydermatis sessile cells was tested using the 2,3-bis(2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium hydroxide (XTT) based assay as previously described [33] . Specifi cally, M. pachydermatis strains were cultured on Dixon agar under aerobic conditions at 32 ° C for 4 days. The cells were transferred into 20 ml of yeast peptone dextrose (YPD; 1% yeast extract, 2% peptone, 2% dextrose) and incubated at 32 ° C, 150 rpm for 2 days. Cultures were centrifuged, the supernatant removed, the cells washed with 20 ml PBS, and then resuspended in YPD at a concentration of ~ 1 ϫ 10 6 CFU/ ml. A total of 200 μ l of each inoculum was deposited in each well of the plate, with the exception of the negative control wells, and the plate incubated at 32 ° C, 150 rpm for 4 days to allow biofi lm formation [13] . The supernatant of each well was aspirated and the wells washed three times with 200 μ l PBS. The plates were dried and 200 μ l of antifungal dilutions deposited in each well containing sessile cells. For each antifungal agent, the lowest dilution tested represented two dilutions under the MIC50 value determined for planktonic cells. The highest dilutions tested represented three dilutions above the MIC50 value for planktonic cells. Hence, the following concentrations were tested; KTZ from 0.008 -0.125 mg/l, ITZ from 0.008 -0.064 mg/l, TER from 0.003 -1 mg/l, VOR from 0.016 -0.5 mg/l, POS from 0.008 -0.125 mg/l, and FLZ 2 -64 mg/l. Plates were incubated at 32 ° C for 2 days.
After incubation, 100 μ l XTT [2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide] with menadione (fi nal concentration of 1 μ M) was added to each well. Plates were incubated in darkness at 32 ° C for 3 h, and 80 μ l aliquot from each well was transferred to another plate and growth measured at 490 nm using a microtiter plate reader [33] . Medium without M. pachydermatis cells, as well as drug-free medium containing fungal cells, were included as negative and positive controls respectively.
The Sessile Minimum Inhibitory Concentration (SMIC) was defi ned as the lowest concentration of the drug which
Results
The MIC values of sessile cells were at least three dilutions higher than those of planktonic cells ( P Յ 0.05) for all antifungal drugs tested (Table 1) . No statistically signifi cant differences in SMIC values were observed between M. pachydermatis collected from animals with (Group B) or without (Group A) skin lesions. For sessile cells of 60 M. pachydermatis isolates tested, 98.3% were classifi ed as resistant to KTZ, followed by 96.7% to TER, 95% to ITZ, 93.3% to POS and 90% FLZ and VOR. Conversely, planktonic cell resistance varied from 8.3% (KTZ) to 0% (ITZ and TER) ( Table 2) , resulting in statistically signifi cant differences between sessile and planktonic cells ( P Ͻ 0.0001). Overall, the results showed an Essential agreement (EA) ranging from 1.7 -15% and a Categorical agreement (CA) ranging from 1.7 -10%, depending upon the antifungal drugs tested. The highest concordance was observed for FLZ (CA 10% and EA 15%) and KTZ (CA 8.3% and EA 13.3%), and the lowest for ITZ (CA 1.7%, and EA 3.3%) and TER (CA 1.7% and EA 1.7%) ( Tables 1 and 2) .
Discussion
This study provides essential information on the antifungal susceptibility of M. pachydermatis cells in both planktonic and sessile forms, and demonstrates that biofi lm formation is responsible for increased antifungal resistance, in agreement with previous reports on other yeasts species [5, 6, 9, 14, 15, 35] . A small number of Malassezia strains displayed azole resistance in the planktonic form, while produces a noticeable decrease in turbidity (i.e., 80% growth inhibition) compared to the positive control [33] . SMIC results are reported as the drug concentration where growth of 50% of isolates tested was inhibited (SIMC50).
Breakpoint interpretation for Malassezia pachydermatis
Breakpoints have not yet been established for M. pachydermatis ; therefore, the following criteria were used to categorize isolates as susceptible (S; MIC sample Յ MIC50), susceptible dose-dependent (SDD; MIC50 Ͻ MIC sample Յ MIC90) or resistant (R; MIC sample Ͼ MIC90) [28] . The interpretative categories (i.e., S, SDD, R) obtained from sessile cells and planktonic cells were compared. Essential agreement (EA) was assigned when there was no more than a two-fold difference between the MICs of sessile and planktonic cells. Categorical agreement (CA) was assigned when planktonic and sessile cells were classifi ed in the same susceptibility category [28] .
Statistical analysis
Normality of data was assessed using the Lilliefors test. The data was assessed using the Wilcoxon Mann-Whitney Test to assess the differences among MIC values of different antifungal agents of sessile and planktonic cells. The Chi-square test was used to compare the occurrence of S, SDD, and R of planktonic and sessile cells. A value of P Յ 0.05 was considered statistically signifi cant. Statistical analyses were performed using the BioEstat 5.0 software [34] . resistance to all drugs tested was observed for sessile forms. Indeed, MIC values of sessile cells were at least three dilutions higher than those of planktonic cells for each antifungal agent. This observation is probably due to a range of factors, including density of biofi lms populations and presence of extracellular matrix. The M. pachydermatis biofi lm structure, represented by clusters of blastoconidia, organized in multi-or monolayers with extracellular matrix production [13] , is likely to act as a barrier against drugs. However, this physiological barrier cannot be solely deemed responsible for biofi lm drug resistance. For example, natural selection of biofi lm cells by apoptosis of sub-lethally damaged cells [36] or overexpression of effl ux pumps encoded by CDR1 , CDR2 , and MDR1 genes [37] could also contribute towards the biofi lm resistance, as has been demonstrated for Candida spp. Nonetheless, as for Candida spp. and other microorganisms, the high antifungal resistance of sessile cells, as observed in this study for M. pachydermatis , could be responsible for treatment failure in Malassezia infections [14,35,38 -41] .
It is known that canine Malassezia infections are usually chronic, with conventional therapy largely ineffective [42, 43] . This may be due to the ability of Malassezia to form biofi lms, consequently requiring higher drug concentrations than are currently used to cure infection [5, 44] . Since the highest CA observed was for FLZ, KTZ and VOR, and 10% of M. pachydermatis sessile cells remained S or SSD for FLZ and VOR, these results advocate these drugs being evaluated for topical and/or systemic treatment of recurrent Malassezia otitis/dermatitis in dogs.
Results from this study confi rm the hypothesis that M. pachydermatis biofi lm formation is associated with antifungal resistance and paves the way towards investigating drug resistance mechanisms in Malassezia spp. 
